Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $49,156. The most recent transaction as insider was on Nov 15, 2022, when has been sold 8,000 shares (Common Stock) at a price of $113.08 per share, resulting in proceeds of $904,640. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130

0% 3M change

0% 12M change

Total Value Held $49,156

MARTINE A ROTHBLATT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Nov 14 2022	SELL Open market or private sale	$2,069,440 $258.68 p/Share	8,000 Reduced 98.4%	130 Common Stock
Nov 14 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Nov 11 2022	SELL Open market or private sale	$2,060,880 $257.61 p/Share	8,000 Reduced 98.4%	130 Common Stock
Nov 11 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Nov 10 2022	SELL Open market or private sale	$2,102,320 $262.79 p/Share	8,000 Reduced 98.4%	130 Common Stock
Nov 10 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Nov 09 2022	SELL Open market or private sale	$2,112,560 $264.07 p/Share	8,000 Reduced 98.4%	130 Common Stock
Nov 09 2022	SELL Open market or private sale	$84,457 $263.93 p/Share	320 Reduced 37.91%	524 Common Stock
Nov 09 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Nov 08 2022	SELL Open market or private sale	$2,025,676 $263.76 p/Share	7,680 Reduced 98.34%	130 Common Stock
Nov 08 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Nov 07 2022	SELL Open market or private sale	$2,133,360 $266.67 p/Share	8,000 Reduced 98.4%	130 Common Stock
Nov 07 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Nov 04 2022	SELL Open market or private sale	$2,124,720 $265.59 p/Share	8,000 Reduced 98.4%	130 Common Stock
Nov 04 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Nov 03 2022	SELL Open market or private sale	$2,106,320 $263.29 p/Share	8,000 Reduced 98.4%	130 Common Stock
Nov 03 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Nov 02 2022	SELL Open market or private sale	$1,986,640 $248.33 p/Share	8,000 Reduced 98.4%	130 Common Stock
Nov 02 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Nov 01 2022	SELL Open market or private sale	$1,848,400 $231.05 p/Share	8,000 Reduced 98.4%	130 Common Stock
Nov 01 2022	BUY Exercise of conversion of derivative security	$904,640 $113.08 p/Share	8,000 Added 49.6%	8,130 Common Stock
Jun 02 2022	SELL Open market or private sale	$131,416 $226.97 p/Share	579 Reduced 81.66%	130 Common Stock
Jun 02 2022	BUY Exercise of conversion of derivative security	$30,930 $53.42 p/Share	579 Added 44.95%	709 Common Stock
Jun 01 2022	SELL Open market or private sale	$692,730 $230.91 p/Share	3,000 Reduced 95.85%	130 Common Stock

MAR

Martine A Rothblatt

Chairperson & CEO

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account